![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0028.png)
28
26.
Falcini F, Trapani S, Ricci L, Resti M, Simonini
G, de Martino M. Sustained improvement of a
girl affected with Devic’s disease over 2 years of
mycophenolate
mofetil
treatment.
Rheumatology
2006;45:913-5.
27.
Jacob A, Matiello M, Weinshenker BG,
Wingerchuk DM, Lucchinetti C, Shuster E, et al.
Treatment of neuromyelitis optica with
mycophenolate mofetil. Retrospective analysis
of 24 patients. Arch Neurol 2009;66:1128-33.
28.
Bichuetti DB, Lobato de Oliveira EM, Oliveira
DM, Amorin de Souza N, Gabbai AA.
Neuromyelitis optica treatment: analysis of 36
patients. Arch Neurol 2010;67:1131-6.
29.
Schwartzman RJ, Simpkins N, Alexander GM,
Reichenberger E, Ward K, Lindenberg N, et al.
High-dose cyclophosphamide in the treatment
of multiple sclerosis. CNS Neurosci Ther 2009
Summer;15:118-27.
30.
Petelin Gadze Z, Hajnsek S, Basic S, Sporis D,
Pavlisa G, Nankovic S. Patient with
neuromyelitis
optica
and
inflammatory
demyelinating lesions comprising whole spinal
cord from C2 level till conus: case report. BMC
Neurol 2009;9:56.
31.
Miyamoto K, Kusunoki S. Intermittent
plasmapheresis
prevents
recurrence
in